Chloé James

8.5k total citations · 1 hit paper
73 papers, 4.3k citations indexed

About

Chloé James is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Chloé James has authored 73 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 38 papers in Genetics and 22 papers in Molecular Biology. Recurrent topics in Chloé James's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (35 papers), Eosinophilic Disorders and Syndromes (19 papers) and Platelet Disorders and Treatments (18 papers). Chloé James is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (35 papers), Eosinophilic Disorders and Syndromes (19 papers) and Platelet Disorders and Treatments (18 papers). Chloé James collaborates with scholars based in France, Australia and United States. Chloé James's co-authors include William Vainchenker, Valérie Ugo, Nicole Casadevall, François Delhommeau, Stefan N. Constantinescu, Jean‐Luc Villeval, Loïc Garçon, Annelise Bennaceur‐Griscelli, Catherine Lacout and Hana Raslová and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Chloé James

70 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

2005 2.5k citations Chloé James, Valérie Ugo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chloé James France	22	3.1k	2.4k	2.1k	1.3k	622	73	4.3k
Stéphane Giraudier France	32	2.4k 0.8×	2.3k 1.0×	1.4k 0.7×	1.2k 1.0×	381 0.6×	117	3.8k
François Delhommeau France	26	3.7k 1.2×	3.0k 1.2×	2.7k 1.3×	1.4k 1.1×	657 1.1×	81	5.2k
Joëlle Guilhot France	33	3.0k 1.0×	3.5k 1.4×	892 0.4×	1.7k 1.4×	717 1.2×	129	4.9k
Francesca Palandri Italy	30	2.2k 0.7×	2.4k 1.0×	653 0.3×	1.2k 1.0×	293 0.5×	180	3.2k
Zbigniew Rudzki Australia	21	2.2k 0.7×	2.7k 1.1×	709 0.3×	1.5k 1.2×	586 0.9×	101	3.8k
Eva Lengfelder Germany	34	1.6k 0.5×	2.6k 1.1×	2.0k 1.0×	507 0.4×	691 1.1×	95	4.2k
Naseema Gangat United States	49	6.9k 2.2×	6.1k 2.5×	4.2k 2.0×	2.3k 1.9×	291 0.5×	333	8.3k
Elisabetta Antonioli Italy	24	2.6k 0.9×	1.8k 0.7×	1.7k 0.8×	1.3k 1.0×	194 0.3×	56	3.3k
David M. Ross Australia	28	2.1k 0.7×	2.6k 1.0×	408 0.2×	1.2k 1.0×	482 0.8×	143	3.0k
Raymond L. Comenzo United States	44	2.1k 0.7×	2.9k 1.2×	6.7k 3.3×	909 0.7×	2.4k 3.9×	230	8.3k

Countries citing papers authored by Chloé James

Since Specialization

Citations

This map shows the geographic impact of Chloé James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloé James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloé James more than expected).

Fields of papers citing papers by Chloé James

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloé James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloé James. The network helps show where Chloé James may publish in the future.

Co-authorship network of co-authors of Chloé James

This figure shows the co-authorship network connecting the top 25 collaborators of Chloé James. A scholar is included among the top collaborators of Chloé James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloé James. Chloé James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rivière, Étienne, Olivier Mansier, Alexandre Guy, et al.. (2025). TRAKJAK: a complete blood count-based prediction of polycythemia vera at initial erythrocytosis workup to reduce financial and ecological costs. The American Journal of Medicine. 139(3). 350–360.

Guy, Alexandre, Pierre‐Emmanuel Morange, & Chloé James. (2024). How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms. Blood. 145(16). 1769–1779. 1 indexed citations

Soumaré, Aïcha, Christophe Tzourio, Stéphanie Debette, et al.. (2024). Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies. eLife. 13. 1 indexed citations

Fiore, Mathieu, Alexandre Guy, & Chloé James. (2024). Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets. Journal of Visualized Experiments. 1 indexed citations

Rivière, Étienne, Rodolphe Thiébaut, Estibaliz Lazaro, et al.. (2023). Assessment of circulating blood lymphocytes in adult patients on rituximab to treat immune thrombocytopenia: Circulating number of NK cells is associated with the response at 6 months. British Journal of Haematology. 202(1). 159–167. 4 indexed citations

Guy, Alexandre, Badr Kilani, Caroline Marty, et al.. (2023). Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms. Journal of Thrombosis and Haemostasis. 22(1). 172–187. 14 indexed citations

Goulenok, Tiphaine, Dorothée Faille, Nadine Ajzenberg, et al.. (2021). Acquired factor V inhibitor: a nation‐wide study of 38 patients. British Journal of Haematology. 192(5). 892–899. 7 indexed citations

Mouton, C., et al.. (2021). A retrospective study of indications and consequences of monitoring direct oral anticoagulant plasma concentrations on patient care in a university hospital: The Retro-AOD study. Thrombosis Research. 206. 76–83. 4 indexed citations

Mansier, Olivier, et al.. (2021). Clonal haematopoiesis and cardiovascular diseases: A growing relationship. Archives of cardiovascular diseases. 114(4). 316–324. 1 indexed citations

10.

Guy, Alexandre, et al.. (2020). Neutrophils prothrombotic characteristics during myeloproliferative neoplasms. Archives of Cardiovascular Diseases Supplements. 12(2-4). 205–205. 5 indexed citations

11.

Guy, Alexandre, Claire Peghaire, Badr Kilani, et al.. (2018). Vascular endothelial cell expression of JAK2^V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression. Haematologica. 104(1). 70–81. 86 indexed citations

12.

Mansier, Olivier, Chloé James, Emmanuelle Verger, et al.. (2015). Quantification of the Mutant CALR Allelic Burden by Digital PCR. Journal of Molecular Diagnostics. 18(1). 68–74. 20 indexed citations

13.

Fiore, Mathieu, Chloé James, C. Mouton, et al.. (2014). Assessment of platelet function with light transmission aggregometry in 24 patients supported with a continuous-flow left ventricular assist device: A single-center experience. Journal of Thoracic and Cardiovascular Surgery. 148(6). 3119–3125.e1. 5 indexed citations

14.

Vandenberg, Cassandra J., Emma C. Josefsson, Kirsteen J. Campbell, et al.. (2014). Loss of Bak enhances lymphocytosis but does not ameliorate thrombocytopaenia in BCL-2 transgenic mice. Cell Death and Differentiation. 21(5). 676–684. 14 indexed citations

15.

Nubret, Karine, et al.. (2013). Acquired von Willebrand disease in a child with a ventricular assist device. Journal of Thoracic and Cardiovascular Surgery. 146(4). e30–e32. 4 indexed citations

16.

James, Chloé, Emma C. Josefsson, Catherine Carmichael, et al.. (2010). Transgenic, inducible RNAi in megakaryocytes and platelets in mice. Journal of Thrombosis and Haemostasis. 8(12). 2751–2756. 10 indexed citations

17.

Delhommeau, François, Didier F. Pisani, Chloé James, et al.. (2006). Oncogenic mechanisms in myeloproliferative disorders. Cellular and Molecular Life Sciences. 63(24). 2939–2953. 51 indexed citations

18.

Ugo, Valérie, Chloé James, & William Vainchenker. (2005). Une mutation unique de la protéine kinase JAK2 dans la polyglobulie de Vaquez et les syndromes myéloprolifératifs non-LMC. médecine/sciences. 21. 669–670. 8 indexed citations

19.

James, Chloé, Valérie Ugo, Nicole Casadevall, Stefan N. Constantinescu, & William Vainchenker. (2005). A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects. Trends in Molecular Medicine. 11(12). 546–554. 90 indexed citations

20.

Naylor, Erik, et al.. (2002). Superior venocaval obstruction secondary to central venous catheter-related thromboses in two patients with metastatic colorectal carcinoma receiving weekly 5-flurouracil. Should adjusted-dose warfarin be used as thromboprophylaxis?. Blood Coagulation & Fibrinolysis. 13(8). 749–753. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact